4//SEC Filing
DeGolyer Donald W 4
Accession 0001583098-25-000005
CIK 0001367644other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:13 PM ET
Size
5.2 KB
Accession
0001583098-25-000005
Insider Transaction Report
Form 4
DeGolyer Donald W
Director
Transactions
- Sale
Common Stock
2025-11-10$10.54/sh−17,801$187,623→ 119,858 total
Footnotes (2)
- [F1]Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on October 2, 2025.
- [F2]For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.33 - $10.79. The Company maintains a record of the transactions and copies will be provided upon request.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001583098
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:13 PM ET
- Size
- 5.2 KB